Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

Neil, Andrew; Cooper, J.A.; Betteridge, J.; Capps, Nigel; McDowell, I.F.W.; N. Durrington, Paul; Seed, Mary; E. Humphries, Steve; behalf of the Simon Broome Familial Hyperlipidaemia Register Group, on

doi:10.1093/eurheartj/ehn422

Public

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

Published in European Heart Journal • May 20, 2008

Authors:

Andrew Neil

J.A. Cooper

J. Betteridge

Abstract

AIMS: To examine the changes in coronary, all-cause, and cancer mortality in patients with heterozygous familial hypercholesterolaemia (FH) before and after lipid-lowering therapy with statins. METHODS AND RESULTS: A total of 3382 patients (1650 men) aged <80 years were recruited from 21 lipid clini...

Subject

Medicine

Statin

Familial hypercholesterolemia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!